Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 2
1952 2
1953 2
1954 1
1958 2
1961 5
1962 5
1963 3
1964 6
1965 3
1966 9
1967 11
1968 8
1969 14
1970 11
1971 15
1972 15
1973 11
1974 22
1975 7
1976 5
1977 3
1978 2
1979 2
1980 2
1981 5
1982 6
1983 4
1984 6
1985 4
1986 1
1987 2
1988 8
1989 4
1990 5
1991 7
1992 9
1993 9
1994 8
1995 17
1996 14
1997 13
1998 8
1999 18
2000 17
2001 17
2002 19
2003 33
2004 11
2005 18
2006 19
2007 23
2008 28
2009 39
2010 46
2011 45
2012 39
2013 39
2014 51
2015 50
2016 57
2017 61
2018 72
2019 94
2020 112
2021 117
2022 117
2023 13
Text availability
Article attribute
Article type
Publication date

Search Results

1,303 results
Results by year
Filters applied: . Clear all
Page 1
MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesis.
Hayashi Y, Kawabata KC, Tanaka Y, Uehara Y, Mabuchi Y, Murakami K, Nishiyama A, Kiryu S, Yoshioka Y, Ota Y, Sugiyama T, Mikami K, Tamura M, Fukushima T, Asada S, Takeda R, Kunisaki Y, Fukuyama T, Yokoyama K, Uchida T, Hagihara M, Ohno N, Usuki K, Tojo A, Katayama Y, Goyama S, Arai F, Tamura T, Nagasawa T, Ochiya T, Inoue D, Kitamura T. Hayashi Y, et al. Among authors: ota y. Cell Rep. 2022 May 10;39(6):110805. doi: 10.1016/j.celrep.2022.110805. Cell Rep. 2022. PMID: 35545056 Free article.
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma.
Hirano M, Imai Y, Kaito Y, Murayama T, Sato K, Ishida T, Yamamoto J, Ito T, Futami M, Ri M, Yasui H, Denda T, Tanaka Y, Ota Y, Nojima M, Kamikubo Y, Gotoh N, Iida S, Handa H, Tojo A. Hirano M, et al. Among authors: ota y. J Exp Clin Cancer Res. 2021 Mar 23;40(1):110. doi: 10.1186/s13046-021-01909-7. J Exp Clin Cancer Res. 2021. PMID: 33757580 Free PMC article.
Biological Nanotherapeutics for Liver Disease.
Driscoll J, Wehrkamp C, Ota Y, Thomas JN, Yan IK, Patel T. Driscoll J, et al. Among authors: ota y. Hepatology. 2021 Nov;74(5):2863-2875. doi: 10.1002/hep.31847. Epub 2021 Aug 30. Hepatology. 2021. PMID: 33825210 Review.
1,303 results